Wedbush Securities’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-19,100
Closed -$47K 1014
2020
Q3
$47K Sell
19,100
-12,500
-40% -$30.8K ﹤0.01% 888
2020
Q2
$112K Sell
31,600
-2,300
-7% -$8.15K 0.01% 847
2020
Q1
$79K Sell
33,900
-8,577
-20% -$20K 0.01% 794
2019
Q4
$93K Sell
42,477
-20,223
-32% -$44.3K 0.01% 931
2019
Q3
$115K Sell
62,700
-58,235
-48% -$107K 0.01% 885
2019
Q2
$175K Buy
120,935
+7,200
+6% +$10.4K 0.02% 855
2019
Q1
$224K Sell
113,735
-31,400
-22% -$61.8K 0.02% 724
2018
Q4
$190K Sell
145,135
-10,850
-7% -$14.2K 0.02% 690
2018
Q3
$384K Sell
155,985
-63,843
-29% -$157K 0.04% 496
2018
Q2
$739K Sell
219,828
-28,083
-11% -$94.4K 0.09% 257
2018
Q1
$1.05M Sell
247,911
-29,266
-11% -$124K 0.14% 178
2017
Q4
$915K Buy
277,177
+17,485
+7% +$57.7K 0.11% 221
2017
Q3
$992K Buy
259,692
+25,000
+11% +$95.5K 0.13% 175
2017
Q2
$1.03M Buy
234,692
+55,000
+31% +$242K 0.13% 183
2017
Q1
$652K Buy
179,692
+5,999
+3% +$21.8K 0.09% 275
2016
Q4
$464K Sell
173,693
-7,252
-4% -$19.4K 0.07% 355
2016
Q3
$590K Sell
180,945
-30,998
-15% -$101K 0.09% 270
2016
Q2
$710K Sell
211,943
-650
-0.3% -$2.18K 0.12% 195
2016
Q1
$519K Sell
212,593
-130
-0.1% -$317 0.09% 249
2015
Q4
$698K Buy
212,723
+12,575
+6% +$41.3K 0.13% 181
2015
Q3
$689K Buy
200,148
+3,000
+2% +$10.3K 0.14% 172
2015
Q2
$262K Sell
197,148
-10,378
-5% -$13.8K 0.05% 473
2015
Q1
$174K Sell
207,526
-1,000
-0.5% -$838 0.03% 602
2014
Q4
$83K Buy
208,526
+7,825
+4% +$3.12K 0.01% 659
2014
Q3
$873K Buy
200,701
+6,855
+4% +$29.8K 0.14% 146
2014
Q2
$960K Buy
+193,846
New +$960K 0.15% 137